THE Therapeutic Goods Administration has released an update on the 'Black Triangle Scheme' which provides a simple way for health professionals and patients to identify certain types of new prescription drugs, and encourage the reporting of adverse events associated with their use.
The black triangle symbol and accompanying text will appear on Product Information and Consumer Medicines Information of products included in the scheme for five years from the date of first supply.
The scheme will start operating in Jan 2018, for all newly registered prescription medicines except biosimilars, generics and seasonal influenza vaccines - see tga.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 13 Oct 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 13 Oct 17